Isracann Biosciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Isracann Biosciences regular Real Value cannot be determined due to lack of data. The prevalent price of Isracann Biosciences is $0.0. Our model calculates the value of Isracann Biosciences from evaluating the firm fundamentals such as Return On Equity of -2.53, shares owned by insiders of 0.50 %, and Return On Asset of -0.35 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Isracann Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Isracann Biosciences is based on 3 months time horizon. Increasing Isracann Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Isracann pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Isracann Biosciences. Since Isracann Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Isracann Pink Sheet. However, Isracann Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Isracann Pink Sheet, also known as its intrinsic value, is the underlying worth of Isracann Biosciences Company, which is reflected in its stock price. It is based on Isracann Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Isracann Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Isracann Biosciences helps investors to forecast how Isracann pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Isracann Biosciences more accurately as focusing exclusively on Isracann Biosciences' fundamentals will not take into account other important factors: Isracann Biosciences Total Value Analysis
Isracann Biosciences is currently estimated to have takeover price of 2.16 M with market capitalization of 2.45 M, debt of 0, and cash on hands of 310.61 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Isracann Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.16 M | 2.45 M | 0 | 310.61 K |
Isracann Biosciences Asset Utilization
One of the ways to look at asset utilization of Isracann is to check how much profit was generated for every dollar of assets it reports. Isracann Biosciences retains a negative application of resources of -0.35 (percent), losing $0.003499 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Isracann Biosciences shows how discouraging it operates for each dollar spent on its resources.Isracann Biosciences Ownership Allocation
Isracann Biosciences has a total of 175.99 Million outstanding shares. Roughly 99.5 (percent) of Isracann Biosciences outstanding shares are held by general public with 0.5 % owned by insiders and only 0.0 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Isracann Biosciences Profitability Analysis
Net Loss for the year was (4.69 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Isracann Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Isracann Biosciences and how it compares across the competition.
About Isracann Biosciences Valuation
The pink sheet valuation mechanism determines Isracann Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Isracann Biosciences. We calculate exposure to Isracann Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Isracann Biosciences's related companies.Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada. Isracann Biosciences is traded on OTC Exchange in the United States.
8 Steps to conduct Isracann Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Isracann Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Isracann Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Isracann Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Isracann Biosciences' revenue streams: Identify Isracann Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Isracann Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Isracann Biosciences' growth potential: Evaluate Isracann Biosciences' management, business model, and growth potential.
- Determine Isracann Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Isracann Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Isracann Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Isracann Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 158.3 M | |
| Retained Earnings | -76.8 M |
Complementary Tools for Isracann Pink Sheet analysis
When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |